ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First-ever all-oral drug for sleeping sickness recommended for approval by EMA committee
November 21, 2018Sanofi’s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a positive opinion from the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHM
Pharma Sources Insight January 2025
